Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 6642 record(s)

Req # A-2023-001513

Adverse Drug Reactions (ADRs) for . Report numbers: E2B_06310879, E2B_06213648.

Organization: Health Canada

25 page(s)
January 2025

Req # A-2024-000142

Adverse Drug Reactions (ADRs). Report numbers: E2B_06948148, E2B_06958436, 001075515, E2B_06965441, E2B_06902373, E2B_06953520.

Organization: Health Canada

92 page(s)
January 2025

Req # A-2024-000182

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-104766-527, Results of Public Opinion Research on Knowledge and Attitudes of Canadians Towards Drug Decriminalization.

Organization: Health Canada

32 page(s)
January 2025

Req # A-2024-000221

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-112319-808, Deputy Heads Steering Committee for Biomanufacturing and Life Sciences.

Organization: Health Canada

13 page(s)
January 2025

Req # A-2024-000261

Adverse Drug Reactions (ADRs). Report numbers: E2B_06680655, E2B_06436087, 1070609.

Organization: Health Canada

32 page(s)
January 2025

Req # A-2024-000351

Adverse Drug Reaction (ADR). Report number: E2B_06904611.

Organization: Health Canada

397 page(s)
January 2025

Req # A-2024-000383

Adverse Drug Reaction (ADR) for Dexilant. Report number: E2B_07056111. ADRs for Entyvio. Report numbers: E2B_07087551, E2B_07067564, E2B_07058648, 001084675, E2B_07087654, E2B_07094025, E2B_07054910, 001082748, E2B_07064687.

Organization: Health Canada

765 page(s)
January 2025

Req # A-2024-000385

Adverse Drug Reaction (ADR) for Alunbrig. Report number: E2B_07054884. ADR for Amphetamine aspartate monohydrate/ amphetamine sulfate/ dextroamphetamine saccharate/ dextroamphetamine sulfate. Report number: E2B_07092490. ADRs for Mesalazine.…

Organization: Health Canada

400 page(s)
January 2025

Req # A-2024-000386

Adverse Drug Reactions (ADRs) for MESALAMINE. Report numbers: E2B_07056269, E2B_07059401, E2B_07057286. ADRs for C1 Esterase Inhibitor (Human). Report numbers: E2B_07094496, E2B_07081568. ADR for GAMMAGARD LIQUID. Report number: 001083422.…

Organization: Health Canada

124 page(s)
January 2025

Req # A-2024-000402

Adverse Drug Reactions (ADRs) for LEUPROLIDE ACETATE. Report numbers: E2B_05884097, E2B_03885413, E2B_06349809.

Organization: Health Canada

139 page(s)
January 2025
Date modified: